tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Zelira Therapeutics Advances Diabetic Neuropathy Study and Strengthens Financial Position
PremiumCompany AnnouncementsZelira Therapeutics Advances Diabetic Neuropathy Study and Strengthens Financial Position
3M ago
Zelira Therapeutics Secures $650,000 R&D Loan Facility to Advance Clinical Trials
Premium
Company Announcements
Zelira Therapeutics Secures $650,000 R&D Loan Facility to Advance Clinical Trials
3M ago
Zelira Therapeutics’ ZLT-L-007 Shows Promising Results in Diabetic Neuropathy Study
Premium
Company Announcements
Zelira Therapeutics’ ZLT-L-007 Shows Promising Results in Diabetic Neuropathy Study
5M ago
Zelira Therapeutics Launches Share Offer to Raise Capital
PremiumCompany AnnouncementsZelira Therapeutics Launches Share Offer to Raise Capital
7M ago
Zelira Therapeutics Announces Proposed Issue of 550,000 Securities
Premium
Company Announcements
Zelira Therapeutics Announces Proposed Issue of 550,000 Securities
7M ago
Zelira Therapeutics Secures $1 Million ATM Funding for Growth
Premium
Company Announcements
Zelira Therapeutics Secures $1 Million ATM Funding for Growth
7M ago
Zelira Therapeutics Announces Change in Director’s Interest
PremiumCompany AnnouncementsZelira Therapeutics Announces Change in Director’s Interest
9M ago
Zelira Therapeutics Issues Convertible Notes
Premium
Company Announcements
Zelira Therapeutics Issues Convertible Notes
10M ago
Zelira Therapeutics Issues 3.5 Million Convertible Notes
Premium
Company Announcements
Zelira Therapeutics Issues 3.5 Million Convertible Notes
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100